Anti-toxoplasmosis activity of herbal medicines: Narrative review
Abstract
Toxoplasmosis is known as a parasitic protozoan disease which is globally distributed. It is caused by Toxoplasma gondii. Sulfadiazine and pyrimethamine are two medicines utilized as parts of a standard therapy for toxoplasmosis. Since the curative medicines currently used in the treatment of toxoplasmosis bring about serious host toxicity, conducting a research on an effective and new substance characterized by relatively low toxicity is required urgently. The naturally derived herbs and plants’ extracts as alternative medicines are getting increasing interest in the world. Various studies have been conducted so far concerning the application of herbal medicines for the treatment of toxoplasmosis, but a research on relatively effective and low toxic substances is still needed. Due to increasing interest in the use of natural products to treat of infectious diseases, we conducted this study. In this review, we have summarized the information of those herbal medicines which are reported to have anti-Toxoplasma gondii activity. We referred to the information databases of Medline, PubMed, Scopus and Google Scholar. The keywords include a combination of T.gondii and some words associated with herbal medicines and natural products.References
Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12):1217-58.
Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992;15(2):211-22.
Arab-Mazar Z, Zamanian MH, Yadegarynia D. Cerebral Toxoplasmosis in an HIV-Negative Patient: A Case Report. Clin Infect Dis. 2016;11(1).
Schmidt DR, Hogh B, Andersen O, Hansen SH, Dalhoff K, Petersen E. Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine. Eur J pediatrics. 2006;165(1):19-25.
Choi W-Y, Nam H-W, Kwak N-H, Huh W, Kim Y-R, Kang M-W, et al. Foodborne outbreaks of human toxoplasmosis. J Infect Dis. 1997;175(5):1280-2.
Lopes FMR, Gonçalves DD, Mitsuka-Breganó R, Freire RL, Navarro IT. Toxoplasma gondii infection in pregnancy. Brazil J Infect Dis. 2007;11(5):496-506.
Değerli K, Kilimcioğlu AA, Kurt Ö, Tamay AT, Özbilgin A. Efficacy of azithromycin in a murine toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey. Acta tropica. 2003;88(1):45-50.
Furtado JM, Smith JR, Belfort R, Gattey D, Winthrop KL. Toxoplasmosis: a global threat. J Global Infect Dis. 2011;3(3):281.
Rahman MA, Mossa JS, Al-Said MS, Al-Yahya MA. Medicinal plant diversity in the flora of Saudi Arabia 1: a report on seven plant families. Fitoterapia. 2004;75(2):149-61.
Emami SA, Asgary S, Naderi GA, Ardekani MR, Aslani S, Airin A, et al. Investigation of antioxidant and anti-glycation properties of essential oils from fruits and branchlets of Juniperus oblonga. Revista Brasileira de Farmacognosia. 2012;22(5):985-93.
Hussain AI, Anwar F, Rasheed S, Nigam PS, Janneh O, Sarker SD. Composition, antioxidant and chemotherapeutic properties of the essential oils from two Origanum species growing in Pakistan. Revista Brasileira de Farmacognosia. 2011;21(6):943-52.
Organization WH. The world health report 2000: health systems: improving performance: World Health Organization; 2000.
Karimi N, Salimikia I, Ramak P, Soheilikhah Z, Shamizadeh M, Gholivand MB. Chemical Composition, Antioxidant and Antimicrobial Activities of Essential Oil from Leutea Kurdistanica Mozaff. Herbal Med J. 2016;1(1).
Rocha L, Almeida J, Macedo R, Barbosa-Filho J. A review of natural products with antileishmanial activity. Phytomedicine. 2005;12(6):514-35.
Vajdian R, Mosaffa N, Tabaei SJS, Kheirandish F, Tarahi MJ, Arab-Mazar Z, et al. Effect of Olive Leaf Extract on Cytokines Secreted by Macrophage. Nov Biomed. 2016;4(3):116-20.
Kheirandish F, Chegeni R, Delfan B, Jabari M, Ebrahimzadeh F, Rashidipour M. The Cytotoxic and Antileishmanial Effects of Satureja khuzestanica Essential Oil. Herbal Med J. 2016;1(1).
Niyyati M, Joneidi Z, KamaliNejad M, Haghighi A, Abadi A, Arab-Mazar Z, et al. In Vitro Activity of Mentha longifolia Leaves and Pimpinella anisum Seeds Against a Clinical Strain of Trichomonas Vaginalis. Int J Mol Clin Microbiol. 2015;5(1):503-9.
Sharif M, Sarvi S, Pagheh AS, Asfaram S, Rahimi MT, Mehrzadi S, et al. The efficacy of herbal medicines against Toxoplasma gondii during the last 3 decades: a systematic review. Canadian J Physiol Pharmacol. 2016;94(12):1237-48.
Gimlette JD, Thomson HW. A Dictionary of Malayan Medicine. A Dictionary of Malayan Medicine. 1939.
Perry LMM. Medicinal plants of east southeast Asia: attributed properties and uses. 1980.
Kavitha N, Noordin R, Chan K-L, Sasidharan S. In vitro anti-Toxoplasma gondii activity of root extract/fractions of Eurycoma longifolia Jack. BMC Complement Altern Med. 2012;12(1):1.
Meusel H, Jager E, Rauschert S, Weinert E. Vergleichende chorologie der zentraleuropaischen flora: Jena, Gustav Fischer Verlag; 1978.
Kerharo J, Adam J-G. La pharmacopée sénégalaise traditionnelle: plantes médicinales et toxiques. 1974.
Ajanohoun J, Ahyi M, Ake-Assi L. Traditional Pharmacopoeia: Contribution to Ethnobotanical and Floristic Studies in Uganda. OAU/STRC Lagos. 1993.
Oluju P, Odoi-Adome R, Anokbonggo W. Traditional Methods In Management of Diarrhoeal Diseases in Uganda. 1990.
Happi EN, Mbosso EJT, Nguemfo EL, Zambou HR, Azebaze AGB. Anti-toxoplasma gondii activity of constituents from Balsamocitrus camerunensis L (Rutaceae). Afr J Med Med Sci. 2014;13(52).
Scott IM, Jensen HR, Philogène BJ, Arnason JT. A review of Piper spp.(Piperaceae) phytochemistry, insecticidal activity and mode of action. Phytochem Reviews. 2008;7(1):65-75.
Sudmoon R, Tanee T, Wongpanich V, Bletter N, Chaveerach A. Ethnobotany and species specific molecular markers of some medicinal sakhan (Piper, Piperaceae). J Med Plants Res. 2012;6(7):1168-75.
Chaveerach A, Mokkamul P, Sudmoon R, Tanee T. Ethnobotany of the genus Piper (Piperaceae) in Thailand. Ethnobot Res Appl. 2006;4:223-31.
Thiengsusuk A, Chaijaroenkul W, Na-Bangchang K. Antimalarial activities of medicinal plants and herbal formulations used in Thai traditional medicine. Parasitol Res. 2013;112(4):1475-81.
Suthanurak M, Sakpakdeejaroen I, Rattarom R, Itharat A. Formulation and stability test of BJ adaptogen tablets for cancer treatment. Planta Medica. 2010;76(12):P102.
Rekha V, Kollipara M, Gupta BS, Bharath Y, Pulicherla KK. A Review on Piper betle L.: Nature’s Promising Medicinal Reservoir. American J Ethno. 2014;1(5):276-89.
Misra P, Kumar A, Khare P, Gupta S, Kumar N, Dube A. Pro-apoptotic effect of the landrace Bangla Mahoba of Piper betle on Leishmania donovani may be due to the high content of eugenol. J Med Microbiol. 2009;58(8):1058-66.
Bagatela BS, Lopes AP, Fonseca FLA, Andreo MA, Nanayakkara DN, Bastos JK, et al. Evaluation of antimicrobial and antimalarial activities of crude extract, fractions and 4-nerolidylcathecol from the aerial parts of Piper umbellata L.(Piperaceae). Nat Prod Res. 2013;27(23):2202-9.
Leesombun A, Boonmasawai S, Shimoda N, Nishikawa Y. Effects of Extracts from Thai Piperaceae Plants against Infection with Toxoplasma gondii. PloS one. 2016;11(5):e0156116.
Rechinger KH. Flora Iranica: JSTOR; 1966.
Zargari A. medicinal plants (1996). Tehran: Tehran Univ Pub.3:513-38.
Hajhashemi V, Sajjadi SE, Zomorodkia M. Antinociceptive and anti-inflammatory activities of Bunium persicum essential oil, hydroalcoholic and polyphenolic extracts in animal models. Pharm Biol. 2011;49(2):146-51.
Sekine T, Sugano M, Majid A, Fujii Y. Antifungal effects of volatile compounds from black zira (Bunium persicum) and other spices and herbs. J chem Eco. 2007;33(11):2123-32.
Talei GR, Mosavi Z. Chemical composition and antibacterial activity of Bunium persicum from west of Iran. Asian J Chem. 2009;21(6):4749.
Kareshk AT, Keyhani A, Mahmoudvand H, Oliaei RT, Asadi A, Andishmand M, et al. Efficacy of the Bunium persicum (Boiss) Essential Oil against Acute Toxoplasmosis in Mice Model. Iranian journal of parasitology. 2015;10(4):625.
Walton NJ, Mayer MJ, Narbad A. Vanillin. Phytochemistry. 2003;63(5):505-15.
Tai A, Sawano T, Yazama F, Ito H. Evaluation of antioxidant activity of vanillin by using multiple antioxidant assays. Biochimica et Biophysica Acta (BBA)-General Subjects. 2011;1810(2):170-7.
Fitzgerald DJ, Stratford M, Narbad A. Analysis of the inhibition of food spoilage yeasts by vanillin. Int J Food Microbiol. 2003;86(1):113-22.
Vaghasiya YK, Nair R, Soni M, Baluja S, Chanda S. Synthesis, structural determination and antibacterial activity of compounds derived from vanillin and 4-aminoantipyrine. J Serb Chem Soc. 2004;69(12):991-8.
Rakchoy S, Suppakul P, Jinkarn T. Antimicrobial effects of vanillin coated solution for coating paperboard intended for packaging bakery products. Asian Journal of Food and Agro-Industry. 2009;2(4):138-47.
Imanishi H, Sasaki Y, Matsumoto K, Watanabe M, Ohta T, Shirasu Y, et al. Suppression of 6-TG-resistant mutations in V79 cells and recessive spot formations in mice by vanillin. Mut Res Letters. 1990;243(2):151-8.
Ohta T, Watanabe M, Watanabe K, Shirasu Y, Kada T. Inhibitory effects of flavourings on mutagenesis induced by chemicals in bacteria. Food Chem Toxicol. 1986;24(1):51-4.
Ho K, Yazan LS, Ismail N, Ismail M. Apoptosis and cell cycle arrest of human colorectal cancer cell line HT-29 induced by vanillin. Cancer Epidemiol. 2009;33(2):155-60.
Oliveira C, Meurer YS, Oliveira MG, Medeiros WM, Silva FO, Brito AC, et al. Comparative study on the antioxidant and anti-Toxoplasma activities of vanillin and its resorcinarene derivative. Molecules. 2014;19(5):5898-912.
Chen S-X, Wu L, Jiang X-G, Feng Y-Y, Cao J-P. Anti-Toxoplasma gondii activity of GAS in vitro. J Ethnopharmacol. 2008;118(3):503-7.
Juan ME, Wenzel U, Ruiz-Gutierrez V, Daniel H, Planas JM. Olive fruit extracts inhibit proliferation and induce apoptosis in HT-29 human colon cancer cells. J Nut. 2006;136(10):2553-7.
Khan NA, Jarroll EL, Panjwani N, Cao Z, Paget TA. Proteases as Markers for Differentiation of Pathogenic and Nonpathogenic Species of Acanthamoeba. J Clin Microbiol. 2000;38(8):2858-61.
Kim JM, Jang DS, Lee YM, Yoo JL, Kim YS, Kim JH, et al. Aldose‐Reductase‐and Protein‐Glycation‐Inhibitory Principles from the Whole Plant of Duchesnea chrysantha. Chem Biodiv. 2008;5(2):352-6.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-5.
Lee IK, Kim DH, Lee SY, Kim KR, Choi SU, Hong JK, et al. Triterpenoic acids of Prunella vulgaris var. lilacina and their cytotoxic activities in vitro. Arch Pharm Res. 2008;31(12):1578-83.
McKerrow JH, Caffrey C, Kelly B, Loke Pn, Sajid M. Proteases in parasitic diseases. Annu Rev Pathol Mech Dis. 2006;1:497-536.
De Pablos LM, González G, Rodrigues R, Garcia Granados A, Parra A, Osuna A. Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii. J Nat Prod. 2010;73(5):831-4.
Frenkel J, Wallace GD. Transmission of toxoplasmosis by tachyzoites: Possibility and probability of a hypothesis. Med Hypotheses. 1979;5(5):529-32.
Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. AmJ Epidemiol. 2001;154(4):357-65.
Wang H, Li Y, Dun L, Xu Y, Jin S, Du J, et al. Antinociceptive effects of oxymatrine from Sophora flavescens, through regulation of NR2B-containing NMDA receptor-ERK/CREB signaling in a mice model of neuropathic pain. Phytomedicine. 2013;20(11):1039-45.
Ma S-C, Du J, But PP-H, Deng X-L, Zhang Y-W, Ooi VE-C, et al. Antiviral Chinese medicinal herbs against respiratory syncytial virus. J Ethnopharm. 2002;79(2):205-11.
Bai L, Zhu L-Y, Yang B-S, Shi L-J, Liu Y, Jiang A-M, et al. Antitumor and immunomodulating activity of a polysaccharide from Sophora flavescens Ait. Int J Biol Macromol. 2012;51(5):705-9.
Hong MH, Lee JY, Jung H, Jin D-H, Go HY, Kim JH, et al. Sophora flavescens Aiton inhibits the production of pro-inflammatory cytokines through inhibition of the NF κB/IκB signal pathway in human mast cell line (HMC-1). Toxicol In Vitro 2009;23(2):251-8.
Kim YC, Kim H-S, Wataya Y, Sohn DH, Kang TH, Kim MS, et al. Antimalarial activity of lavandulyl flavanones isolated from the roots of Sophora flavescens. Biol Pharm Bulletin. 2004;27(5):748-50.
Choi K-M, Gang J, Yun J. Anti-Toxoplasma gondii RH strain activity of herbal extracts used in traditional medicine. Int J Antimic Agents. 2008;32(4):360-2.
Youn H, Lakritz J, Kim D, Rottinghaus G, Marsh A. Anti-protozoal efficacy of medicinal herb extracts against Toxoplasma gondii and Neospora caninum. Veterinary Parasitology. 2003;116(1):7-14.
Miao K, Zhang J, Dong Y, Xi Y. Research progress on the chemical compounds and pharmacology of Sophora flavescens. Natural Product Research and Development. 2000;13(2):69-73.
Zhang X, Jin L, Cui Z, Zhang C, Wu X, Park H, et al. Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo. Exp Parasitol. 2016;165:95-102.
Al Nasr I, Ahmed F, Pullishery F, El-Ashram S, Ramaiah VV. Toxoplasmosis and anti-Toxoplasma effects of medicinal plant extracts-A mini-review. Asian Pac J Trop Med. 2016;9(8):730-4.
Benoit-Vical F, Santillana-Hayat M, Kone-Bamba D, Mallie M, Derouin F. Anti-Toxoplasma activity of vegetal extracts used in West African traditional medicine. Parasite. 2000;7(1):3-7.
Rostami A, Taheri M, Gholizadeh M, Seyyedtabaei SJ, Raeghi S, Fallahi S. Scolicidal Effect of Some Herbs on Echinococcus granulosus Protoscoleces: a Systematic Literature Review. Herbal Med J. 2016;1(1).
Johji Y, Michihiko M, Rong HQ, Hisashi M, Hajime F. The anti-ulcer effect in rats of ginger constituents. J Ethnopharm. 1988;23(2-3):299-304.
Grzanna R, Lindmark L, Frondoza CG. Ginger-an herbal medicinal product with broad anti-inflammatory actions. J Med food. 2005;8(2):125-32.
Shukla Y, Singh M. Cancer preventive properties of ginger: a brief review. Food Chem Toxicol . 2007;45(5):683-90.
Jagetia GC, Baliga MS, Venkatesh P, Ulloor JN. Influence of ginger rhizome (Zingiber officinale Rosc) on survival, glutathione and lipid peroxidation in mice after whole-body exposure to gamma radiation. Rad Res. 2003;160(5):584-92.
Ficker CE, Arnason J, Vindas P, Alvarez L, Akpagana K, Gbeassor M, et al. Inhibition of human pathogenic fungi by ethnobotanically selected plant extracts. Mycoses. 2003;46(1‐2):29-37.
Choi W, Jiang M, Chu J. Antiparasitic effects of Zingiber officinale (Ginger) extract against Toxoplasma gondii. J Appl Biomed. 2013;11(1):15-26.
Bilia A, de Malgalhaes PM, Bergonzi M, Vincieri F. Simultaneous analysis of artemisinin and flavonoids of several extracts of Artemisia annua L. obtained from a commercial sample and a selected cultivar. Phytomedicine. 2006;13(7):487-93.
de Oliveira TC, Silva DAO, Rostkowska C, Béla SR, Ferro EA, Magalhães PM, et al. Toxoplasma gondii: Effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo. Exp Parasitol. 2009;122(3):233-41.
Jasim M. Evaluation of Antibacterial effect of extracted fatty acids of Nutmeg Myristica fragrans (Houtt.) against locally isolated bacteria.
Burkill IH. A dictionary of the economic products of the Malay Peninsula. A Dictionary of the Economic Products of the Malay Peninsula. 1966;2(2nd edition).
OZAKI Y, SOEDIGDO S, WATTIMENA YR, SUGANDA AG. Antiinflammatory effect of mace, aril of Myristica fragrans Houtt., and its active principles. Jpn J Pharmacol. 1989;49(2):155-63.
Jukić M, Politeo O, Miloš M. Chemical composition and antioxidant effect of free volatile aglycones from nutmeg (Myristica fragrans Houtt.) compared to its essential oil. Croatica chemica ACTA. 2006;79(2):209-14.
Pillai S, Mahmud R, Lee WC, Perumal S. Anti-parasitic activity of Myristica fragrans Houtt. essential oil against Toxoplasma gondii parasite. APCBEE Procedia. 2012;2:92-6.
Renslo AR, McKerrow JH. Drug discovery and development for neglected parasitic diseases. Nat Chem Biol. 2006;2(12):701-10.
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation. Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This work is licensed under a Creative Commons license (CC-BY). However, the license permits any user to read, copy, redistribute and and make derivative the material in any medium or format for any purpose, even commercially.
